Table 4.
Subgroup analysis: ES and SRM of delta 1 and delta 2 in patients receiving chemotherapy.
| HRQoL | SRM: Delta 1 | SRM: Delta 2 | ES: Delta 1 | ES: Delta 2 |
|---|---|---|---|---|
| EQ-5D-5L | ||||
| Index | −0.331 | −0.141 | −0.394 | −0.172 |
| VAS score | −0.221 | −0.050 | −0.247 | −0.049 |
| EORTC QLQ-C30 | ||||
| Global Quality of Life scale | −0.260 | 0.013 | −0.296 | 0.013 |
| Physical functioning | −0.436 | −0.149 | −0.399 | −0.140 |
| Role functioning | −0.381 | −0.079 | −0.452 | −0.097 |
| Emotional functioning | 0.126 | 0.300 | 0.149 | 0.341 |
| Cognitive functioning | −0.403 | −0.291 | −0.563 | −0.373 |
| Social functioning | −0.298 | −0.083 | −0.386 | −0.095 |
| Fatigue | 0.380 | 0.055 | 0.435 | 0.058 |
| Nausea and vomiting | −0.042 | −0.125 | −0.053 | −0.141 |
| Pain | 0.351 | 0.237 | 0.501 | 0.293 |
| Dyspnea | 0.294 | 0 | 0.475 | 0 |
| Insomnia | 0.008 | −0.112 | 0.009 | −0.139 |
| Appetite loss | −0.334 | −0.505 | −0.41 | −0.540 |
| Constipation | −0.021 | 0 | −0.022 | 0 |
| Diarrhea | −0.156 | −0.209 | −0.198 | −0.255 |
| Financial difficulties | 0.308 | 0.233 | 0.465 | 0.310 |
| Summary score | −0.236 | 0.060 | −0.282 | 0.067 |
Abbreviations: SRM, standardized response mean; ES, effect size. Note: delta 1, difference in scores between T0 and T6; delta 2, difference in scores between T0 and T12. Bold indicates SRM/ES > 0.5.